Artemis Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Artemis Investment Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-240,322	Closed	-$3.36M	–	219
2025 Q3	$3.36M	Buy	240,322 +105,092	+78%	+$1.51M	0.04%	171
2025 Q2	$2.03M	Sell	135,230 -146,300	-52%	-$2.09M	0.03%	182
2025 Q1	$3.71M	Sell	281,530 -14,000	-5%	-$193K	0.06%	174
2024 Q4	$4.67M	Sell	295,530 -1,000	-0.3%	-$15K	0.07%	172
2024 Q3	$4.71M	Buy	296,530 +218,530	+280%	+$3.52M	0.07%	168
2024 Q2	$1.19M	Buy	78,000 +37,500	+93%	+$537K	0.02%	183
2024 Q1	$594K	Buy	+40,500	New	+$591K	0.01%	193

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Artemis Investment Management's RDY Position: Q4 2025 in Review

Artemis Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 240,322 shares — an estimated $3.36M sold.

Artemis Investment Management first reported a position in RDY in Q1 2024 and held it in 7 quarters. The position peaked at $4.71M in Q3 2024. 235 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

Artemis Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
Artemis Investment Management sold 240,322 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $3.36M.
Artemis Investment Management first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 7 quarters.
Artemis Investment Management's Dr. Reddy's Laboratories position peaked at $4.71M in Q3 2024.
235 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Artemis Investment Management's 13F filing for Q4 2025, filed 2 Feb 2026.